BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 2, 2007
View Archived Issues
$50M Invested In Microbia For Late-Stage Drug Trials
Microbia Inc. raised $50 million in private equity to push product development, with a particular focus on multiple Phase II studies of its two lead products. (BioWorld Today)
Read More
EUSA Launches With $175M Financing, OPi Acquisition
Read More
New Fly Model Of PolyQ Disease Shows Vicious Instability Loop
Read More
Point Shares Fall On Mixed Phase III, Bad Phase II Update
Read More
Sirtris Seeks $60M To Advance Sirtuin-Red Wine Connection
Read More
Other News To Note
Read More
Clinic Roundup
Read More